2015
DOI: 10.21767/2386-5180.100011
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Significance of Cystatin C-Based Estimates of Renal Function in Type 2 Diabetic Patients: Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…These equations were useful for early detection of renal dysfunction and is a better risk predictor amongst patients with diabetic mellitus when compared to the creatinine-based eGFR equations. 20 Rapid detection of reduced renal function will allow earlier intervention and hence, prevent further deterioration of kidney problem. Cystatin C-based eGFR showed a better accuracy in predicting prognosis when compared to creatinine-based eGFR, thus utilisation of cystatin C was suggested.…”
Section: Introductionmentioning
confidence: 99%
“…These equations were useful for early detection of renal dysfunction and is a better risk predictor amongst patients with diabetic mellitus when compared to the creatinine-based eGFR equations. 20 Rapid detection of reduced renal function will allow earlier intervention and hence, prevent further deterioration of kidney problem. Cystatin C-based eGFR showed a better accuracy in predicting prognosis when compared to creatinine-based eGFR, thus utilisation of cystatin C was suggested.…”
Section: Introductionmentioning
confidence: 99%
“…Cystatin‐C is not routinely found in urine in significant quantities . Raised urinary altitudes of cystatin‐C may reveal tubular dysfunction independent of GFR . Acute cystatin‐C fluctuations may consequently afford more truthful AKI diagnosis; this would upsurge authority of novel biomarker and of AKI‐outcome studies .…”
Section: Introductionmentioning
confidence: 99%
“…[6] Raised urinary altitudes of cystatin-C may reveal tubular dysfunction independent of GFR. [7] Acute cystatin-C fluctuations may consequently afford more truthful AKI diagnosis; this would upsurge authority of novel biomarker and of AKI-outcome studies. [8] Some studies have proposed that serum cystatin-C upswing with AKI befalls before rise in SCr, leading to assessment of cystatin-C as an early AKI biomarker.…”
Section: Introductionmentioning
confidence: 99%